EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children

Tena Niseteo iD, Iva Hojsak, Suzana Ožanić Bulić, Nives Pustišek

Nutrients · 24.08.2024 · 16 (17) · 2829

DOI: 10.3390/nu16172829 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 24.08.2024. Verfasst von Tena Niseteo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Dietary Supplements, Fatty Acids, Omega-3, gamma-Linolenic Acid. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 4U pharma, gmbh, Swicerland, 4U Pharma Gmbh.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of omega-3 fatty acids (omega-3 FA) in the treatment of atopic dermatitis (AD) is an area of ongoing research. Some studies suggest that dietary supplementation with omega-3 FA can help manage symptoms of AD by reducing lesion severity, skin inflammation, dryness and itching, while others show no significant beneficial effect. The aim of this study was to evaluate the effect of omega-3 FA from fish oil in combination with gamma-linolenic acid (GLA) from blackcurrant seed oil in children with AD. This is a longitudinal, prospective, randomized, triple blind, placebo-controlled parallel clinical trial. The study was conducted during the 2-year period throughout autumn, winter, and spring, avoiding the summer when AD usually improves. Children were randomized to receive the active study product (Mega Kid®) containing a specific blend of omega-3 and omega-6 fatty acids or placebo. The primary outcomes were changes in severity of AD measured using SCORing Atopic Dermatitis (SCORAD), patient-oriented SCORAD (PO-SCORAD) and the difference in topical corticosteroid (TCS) use. The secondary outcomes were changes in itch intensity, sleep quality and Family Dermatology Life Quality Index (FDLQI). Data were analyzed for 52 children (26 in the intervention group and 26 in the placebo group). In children receiving the active product, intention-to-treat analysis showed that after 4 months of treatment, there was a significant decrease in the SCORAD index (from median 42 to 25, p < 0.001) and the use of topical corticosteroids (from median 30 to 10 mg/month, p < 0.001), but also significant improvements in itch, sleep quality, and overall quality of life. Omega-3 fatty acids in combination with GLA and vitamin D may decrease symptoms and were associated with an improvement clinical picture of AD in children. Therefore, we can conclude that supplementation with this specific combination could be considered a safe and effective intervention that may significantly reduce the severity of AD in pediatric patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicDietary SupplementsFatty Acids, Omega-3gamma-Linolenic AcidChildChild, PreschoolFemaleHumansMaleLongitudinal StudiesProspective StudiesPruritusQuality of LifeSeverity of Illness IndexTreatment Outcome

Stichwörter der Autor:innen

atopic dermatitischildrendocosahexaenoic acid (DHA)eicosapentaenoic acid (EPA)gamma-linolenic acid (GLA)omega-3 fatty acids

Substanzen

Fatty Acids, Omega-3gamma-Linolenic Acid

Autor:innen und Institutionen

  • Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, 10000 Zagreb, Croatia.
  • Faculty of Food Technology and Biotechnology, University of Zagreb, 10000 Zagreb, Croatia.
  • Department of Pediatrics, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
  • Department of Pediatrics, School of Medicine, University J.J. Strossmayer, 31000 Osijek, Croatia.
  • Department of Pediatric and Adolescent Dermatology and Venerology, Children's Hospital Zagreb, 10000 Zagreb, Croatia.

ORCID-Profile: Tena Niseteo

Förderung

  • 4U pharma, gmbh, Swicerland
  • 4U Pharma Gmbh

Zitieren

APA

Niseteo, T., Hojsak, I., Ožanić Bulić, S., & Pustišek, N. (2024). Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children. Nutrients, 16(17), 2829. https://doi.org/10.3390/nu16172829

Vancouver

Niseteo T, Hojsak I, Ožanić Bulić S, Pustišek N. Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children. Nutrients. 2024;16(17):2829. doi:10.3390/nu16172829

BibTeX
@article{Niseteo2024,
  author = {Niseteo, Tena and Hojsak, Iva and Ožanić Bulić, Suzana and Pustišek, Nives},
  title = {Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {17},
  pages = {2829},
  doi = {10.3390/nu16172829}
}
Kostenlos starten →